FDAnews Device Daily Bulletin
Medical Devices / Commercial Operations

Tandem Announces Expanded Indication for Insulin Pump

July 27, 2016

Tandem Diabetes Care revealed that the FDA has broadened the indication for its t:slim insulin pump, clearing it for patients as young as 6 years old. The previous indication was for those 12 and over.

The touchscreen pump holds 300 units of insulin and tracks current insulin levels. — Cynthia Jessup

View today's stories